Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial.
Hasan A, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Karch S, Schneider-Axmann T, Falkai P, Wobrock T. Hasan A, et al. Among authors: hajak g. Schizophr Bull. 2016 May;42(3):608-18. doi: 10.1093/schbul/sbv142. Epub 2015 Oct 3. Schizophr Bull. 2016. PMID: 26433217 Free PMC article. Clinical Trial.
Antipsychotic treatment with quetiapine increases the cortical silent period.
Frank E, Landgrebe M, Poeppl TB, Schecklmann M, Kreuzer PM, Prasser J, Rupprecht R, Eichhammer P, Hajak G, Langguth B. Frank E, et al. Among authors: hajak g. Schizophr Res. 2014 Jun;156(1):128-32. doi: 10.1016/j.schres.2014.03.028. Epub 2014 Apr 29. Schizophr Res. 2014. PMID: 24794881
Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial.
Wobrock T, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A. Wobrock T, et al. Among authors: hajak g. Biol Psychiatry. 2015 Jun 1;77(11):979-88. doi: 10.1016/j.biopsych.2014.10.009. Epub 2014 Oct 23. Biol Psychiatry. 2015. PMID: 25582269 Clinical Trial.
Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia.
Kamp D, Engelke C, Wobrock T, Kunze B, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Raees A, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A, Cordes J. Kamp D, et al. Among authors: hajak g. Schizophr Res. 2018 Feb;192:481-484. doi: 10.1016/j.schres.2017.05.036. Epub 2017 Jun 1. Schizophr Res. 2018. PMID: 28578924 Clinical Trial. No abstract available.
1-Hz rTMS in the treatment of tinnitus: A sham-controlled, randomized multicenter trial.
Landgrebe M, Hajak G, Wolf S, Padberg F, Klupp P, Fallgatter AJ, Polak T, Höppner J, Haker R, Cordes J, Klenzner T, Schönfeldt-Lecuona C, Kammer T, Graf E, Koller M, Kleinjung T, Lehner A, Schecklmann M, Pöppl TB, Kreuzer P, Frank E, Langguth B. Landgrebe M, et al. Among authors: hajak g. Brain Stimul. 2017 Nov-Dec;10(6):1112-1120. doi: 10.1016/j.brs.2017.08.001. Epub 2017 Aug 5. Brain Stimul. 2017. PMID: 28807845 Clinical Trial.
Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis.
Koutsouleris N, Wobrock T, Guse B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Musso F, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Dwyer D, Ghaseminejad F, Dechent P, Malchow B, Kreuzer PM, Poeppl TB, Schneider-Axmann T, Falkai P, Hasan A. Koutsouleris N, et al. Among authors: hajak g. Schizophr Bull. 2018 Aug 20;44(5):1021-1034. doi: 10.1093/schbul/sbx114. Schizophr Bull. 2018. PMID: 28981875 Free PMC article. Clinical Trial.
Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
Hansbauer M, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A. Hansbauer M, et al. Among authors: hajak g. Psychiatry Res. 2018 May;263:22-29. doi: 10.1016/j.psychres.2018.02.030. Epub 2018 Feb 17. Psychiatry Res. 2018. PMID: 29482042 Clinical Trial.
Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.
Kamp D, Engelke C, Wobrock T, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Raees A, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A, Cordes J. Kamp D, et al. Among authors: hajak g. Schizophr Res. 2019 Feb;204:445-447. doi: 10.1016/j.schres.2018.09.017. Epub 2018 Sep 22. Schizophr Res. 2019. PMID: 30249471 Clinical Trial. No abstract available.
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.
Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Siskind D, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A. Wagner E, et al. Among authors: hajak g. Schizophr Res. 2019 Jun;208:370-376. doi: 10.1016/j.schres.2019.01.021. Epub 2019 Jan 29. Schizophr Res. 2019. PMID: 30704862 Clinical Trial.
366 results